Autologous Platelet Rich Plasma Injection for Scar Rejuvenation – A Prospective Observational Study
International Journal of Current Pharmaceutical Review and Research · 11.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.57 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 11.03.2026. Verfasst von Athira C. und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Platelet-rich plasma (PRP) is an autologous blood product enriched with platelets, growth factors and cytokines, concentrated in a small plasma volume. Since the 1970s, PRP has gained significant attention for its role in tissue repair and regeneration. The use of autologous PRP eliminates risks of cross-reactivity, immune reactions or disease transmission. This study aimed to evaluate the effectiveness of platelet-rich plasma (PRP) monotherapy for scar rejuvenation, as no prior clinical studies have objectively assessed its outcomes using a validated tool.
Objective
To study the effect of injection of autologous platelet rich plasma in the rejuvenation of scars among patients attending Plastic Surgery OPD in Government Medical College, Thiruvananthapuram, for a period of 1 year.
Methods
The study included 40 patients with scars who received PRP injections. Patient and Observer Scar Assessment Scale (POSAS) score was marked on the proforma after obtaining consent and the patients were reassessed at regular intervals. The decrease in POSAS score was statistically analysed using SPSS version 27.
Results
There was a statistically significant decrease in POSAS score on both the patient and observer sides after PRP injection. Among 40 patients, mean age was 30.7 years (range: 18–46), 65% female. Scars were located on the head/neck (57%), upper limbs (20%), trunk (18%), and lower limbs (5%). Causes included road traffic accidents (70%), post-surgical scars (17.5%), and burns (12.5%). The mean pre-procedure POSAS patient score was 28.97 (SD: 2.09), decreasing to 26 post-procedures (SD: 2.12). Pain and itch showed no significant changes (p > 0.05), while other variables improved significantly (p < 0.05). Similarly, the mean POSAS observer score decreased from 28.4 (SD: 2.023) to 25 (SD: 2.36) post-procedure.
Conclusion
Injection of PRP seems to be a promising and effective therapeutic approach for scars with different origins such as trauma, burns, and post-surgery. Treated areas regain characteristics similar to normal skin, leading not only to aesthetic but also functional results.
Zitieren
APA
C., A., P., B., S., A. P., & P., P. A. (2026). Autologous Platelet Rich Plasma Injection for Scar Rejuvenation – A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.57
Vancouver
C. A, P. B, S. AP, P. PA. Autologous Platelet Rich Plasma Injection for Scar Rejuvenation – A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.57
BibTeX
@article{C2026,
author = {C., Athira and P., Binod and S., Ajith P. and P., Premlal A.},
title = {Autologous Platelet Rich Plasma Injection for Scar Rejuvenation – A Prospective Observational Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.57}
}
EUVIMED